Akebia Therapeutics Stock (NASDAQ: AKBA) stock price, news, charts, stock research, profile.
Open | $1.40 |
Close | - |
Volume / Avg. | 479.30K / 3.29M |
Day Range | 1.37 - 1.43 |
52 Wk Range | 0.78 - 2.48 |
Market Cap | $285.07M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 67 |
Short Interest | 6.32% |
Days to Cover | 2.01 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Akebia Therapeutics (NASDAQ:AKBA) through any online brokerage.
Other companies in Akebia Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Tectonic Therapeutic (NASDAQ:TECX), bluebird bio (NASDAQ:BLUE), Zentalis Pharma (NASDAQ:ZNTL) and Inovio Pharmaceuticals (NASDAQ:INO).
There is no analysis for Akebia Therapeutics.
Akebia Therapeutics has a consensus price target of $4.67.
The stock price for Akebia Therapeutics (NASDAQ: AKBA) is $1.3601 last updated Today at July 17, 2024 at 10:25 AM EDT.
There are no upcoming dividends for Akebia Therapeutics.
Akebia Therapeutics’s Q2 earnings are confirmed for Friday, August 23, 2024.
There is no upcoming split for Akebia Therapeutics.
Akebia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.